Liraglutide Reduces Liver Steatosis and Improves Metabolic Indices in Obese Patients Without Diabetes: A 3-Month Prospective Study.

Int J Mol Sci · 2025 · PMC12192618 · PMID 40565353

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although this numerical decrease corresponded to a shift to stage 2 steatosis, the change in the liver steatosis stage did not reach statistical significance ( Table 3 ). 2.3.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.